Detalles de la búsqueda
1.
Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
Biol Blood Marrow Transplant
; 20(4): 556-63, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24447907
2.
Modified EBMT Pretransplant Risk Score Can Identify Favorable-risk Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for AML, Not Identified by the HCT-CI Score.
Clin Lymphoma Myeloma Leuk
; 15(5): e73-81, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25458081
3.
A comparison of long-term outcomes of donor lymphocyte infusions and tyrosine kinase inhibitors in patients with relapsed CML after allogeneic hematopoietic cell transplantation.
Clin Lymphoma Myeloma Leuk
; 14(1): 87-92, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24252361
4.
Molecular relapse after allogeneic hematopoietic cell transplant for chronic myeloid leukemia: some long-term survivors appear to tolerate even lack of major molecular response.
Leuk Lymphoma
; 55(10): 2398-401, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24428200
Resultados
1 -
4
de 4
1
Próxima >
>>